Cancer drugs conferring low or no therapeutic benefits accounted for $6.7 billion in post-rebate Medicare spending in 2022.

Outpatient administration of CAR T-cell therapies can reduce costs and improve patient satisfaction, with evolving ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

A new study found a correlation between regular use of a popular over the counter drug and a decreased risk in certain types ...

Dr. Laura Finn brings new treatment options to Louisiana using genetically altered cells to treat blood cancer patients. Here ...

New research suggests that an “often-overlooked” parasitic infection, already linked to bladder cancer, may also raise the risk of cervical cancer.

OSU scientists created nanoparticles that deliver anti-inflammatory drugs across the blood-brain barrier, offering hope for ...

Lenny Santoro credits NIH research with saving his life longer than doctors expected. Duke Health's Dr. Daniel George warns ...

A new medication is helping doctors identify tumors during lung cancer surgery. Cytalux, an FDA-approved dye, is administered ...

Michelle Xia represents a rising generation of biotech companies in China challenging Western giants.

Omeros forms oncology committee to guide development of its AML therapy, which showed strong efficacy and safety in ...

Berberine is a powder made from different plants. It has many benefits, including improving blood sugar levels, reducing ...